
Neogen Corporation NEOG
$ 9.23
-0.65%
Quarterly report 2026-Q1
added 04-09-2026
Neogen Corporation Operating Cash Flow 2011-2026 | NEOG
Annual Operating Cash Flow Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58.2 M | 35.3 M | 41 M | 68 M | 81.1 M | 85.9 M | 63.8 M | 69.1 M | 60.3 M | 35.3 M | - | 21.7 M | 26.6 M | 22.3 M | 28.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 85.9 M | 21.7 M | 49.8 M |
Quarterly Operating Cash Flow Neogen Corporation
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 10.9 M | - | - | - | -17.9 M | - | - | - | 23 M | - | - | - | -14.1 M | -32.9 M | - | - | 23.2 M | 41.1 M | - | - | 25.1 M | 47.5 M | - | - | 23.7 M | 40.5 M | 23.7 M | - | 16.1 M | 32.6 M | 16.1 M | - | 18.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.51 M | 10.7 M | - | - | 4.44 M | 11.3 M | 4.44 M | - | 1.35 M | 6.17 M | 1.35 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 47.5 M | -32.9 M | 13.4 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 205.06 | 0.27 % | $ 22.8 B | ||
|
Celcuity
CELC
|
-153 M | $ 89.08 | -3.79 % | $ 4.17 B | ||
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-29.1 M | $ 4.22 | -6.22 % | $ 5.61 M | ||
|
Castle Biosciences
CSTL
|
64.3 M | $ 21.08 | - | $ 611 M | ||
|
Fulgent Genetics
FLGT
|
-102 M | $ 19.02 | 2.78 % | $ 585 M | ||
|
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-24.2 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
1.04 B | $ 149.4 | -1.59 % | $ 11.7 B | ||
|
Guardant Health
GH
|
-185 M | $ 130.85 | 0.56 % | $ 16.4 B | ||
|
Illumina
ILMN
|
1.08 B | $ 164.29 | 2.66 % | $ 25.5 B | ||
|
CareDx, Inc
CDNA
|
42 M | $ 23.06 | 1.36 % | $ 1.23 B | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-46 K | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
5.83 M | $ 1.79 | 2.87 % | $ 7.92 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-9.68 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-460 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
390 M | $ 101.94 | 1.96 % | $ 6.88 B | ||
|
Charles River Laboratories International
CRL
|
738 M | $ 189.61 | -0.2 % | $ 9.4 B | ||
|
Pacific Biosciences of California
PACB
|
-111 M | $ 1.38 | 0.36 % | $ 414 M | ||
|
Medpace Holdings
MEDP
|
713 M | $ 473.04 | 1.34 % | $ 13.6 B | ||
|
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
956 M | $ 1 135.13 | -2.39 % | $ 23.4 B | ||
|
NeoGenomics
NEO
|
5.23 M | $ 11.71 | 2.32 % | $ 1.5 B | ||
|
Myriad Genetics
MYGN
|
1.8 M | $ 4.63 | 1.98 % | $ 429 M | ||
|
National Research Corporation
NRC
|
26.4 M | $ 19.93 | 0.91 % | $ 446 M | ||
|
Natera
NTRA
|
215 M | $ 216.72 | -2.74 % | $ 29.6 B | ||
|
Personalis
PSNL
|
-74.9 M | $ 9.69 | -0.62 % | $ 865 M | ||
|
Senseonics Holdings
SENS
|
-59.1 M | $ 7.23 | -2.69 % | $ 302 M | ||
|
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
46.8 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-3.84 M | $ 2.04 | -0.54 % | $ 4.69 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 272.38 | 0.44 % | $ 22.7 B | ||
|
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 68.29 | -2.53 % | $ 4.08 B | ||
|
Thermo Fisher Scientific
TMO
|
7.82 B | $ 486.89 | -1.51 % | $ 184 B | ||
|
Trinity Biotech plc
TRIB
|
-4.19 M | $ 0.67 | 1.61 % | $ 241 M | ||
|
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | ||
|
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M |